(Q33965076)

30 July 2017

1 reference

title

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

1 reference

Christian Gluud

4

0 references

author name string

Jianping Liu

series ordinal

1

1 reference

30 July 2017

Eric Manheimer

series ordinal

2

1 reference

30 July 2017

Kiichiro Tsutani

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

The American Journal of Gastroenterology

30 July 2017

1 reference

30 July 2017

98

1 reference

30 July 2017

3

1 reference

30 July 2017

538-544

1 reference

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Recent advances: complementary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

A review of 12 commonly used medicinal herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Treatment of chronic liver diseases with traditional Chinese medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Liver enzyme elevations in patients treated with traditional Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Toxicity of complementary therapies: an eastern perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

The role of nitric oxide in the inhibition of gastric epithelial proliferation in portal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07298.X

10.1111/J.1572-0241.2003.07298.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference